For instance, rolipram ameliorated cognitive dysfunction in a mouse model of AD by reducing neuronal damage31, and it has been proven to increase the phosphorylation of cAMP responsive element binding protein (CREB) and limit the expression of TNF-α and IL-10 in β-amyloid-induced cognitive impairment32. This evidence concerns the gene TNF and Alzheimer disease.